Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adolescent medicine
advances in neurology
Alzheimer's disease
amyloid angiopathy, cerebral
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, childhood
amyotrophic lateral sclerosis, familial
amyotrophic lateral sclerosis, Parkinson-dementia-complex
amyotrophic lateral sclerosis, post-encephalitic
anticholinergic drugs
apraxia of eyelid opening
athetosis
athetosis, causes of
atlanto axial dislocation, congenital
basal ganglia
basal ganglia, degeneration
benign essential tremor
biologic markers
biopterin deficiency
bradykinesia
brain biopsy
cavernous sinus, syndrome
cerebral palsy
cerebrospinal fluid
cerebrospinal fluid, gamma amino butyric acid
children
chorea
chorea, causes of
cogwheel rigidty
degenerative diseases of CNS
dementia
dementia, frontotemporal
dementia, subcortical
differential diagnosis
dopa responsive dystonia
dopamine
dyskinesia
dyskinesia, causes of
dyskinesia, drug induced
dystonia
dystonia musculorum deformens
dystonia, treatment of
electromyogram
encephalocele
epidemiology of neurology
equinovarus
exercise
exercise-induced neurologic dysfunction
extrapyramidal
familial
fasciculation
Friedreich's ataxia
gait disorder
gamma amino butyric acid
gene mutation
genetic neurologic disorders
genetic testing
Gilles de la Tourette syndrome
hemangioma
hepatolenticular degeneration(Wilson's disease)
homovanillic acid
Huntington's chorea
hydroxyindole acetic acid 5(5HIAA)
hypoxic encephalopathy
imbalance
inclusion bodies, intranuclear
infantile tremor syndrome
Jakob-Creutzfeldt disease
L-dopa
Lewy body disease, diffuse
malformation, CNS, congenital
malformation, vascular
malformation, vascular, cerebral
masked facies
mimics
misdiagnosis
molecular genetics
motor neuron disease
motor neuron disease, juvenile form
movement disorder
movement disorder, extrapyramidal
movement disorder, treatment of
MRI, abnormal
MRI, functional
multiple sclerosis
multiple system atrophy
myoclonus
neurologic disease, diagnoses of
neuronal intranuclear inclusion disease
neurotransmitter
ophthalmoplegia
ophthalmoplegia, painful
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, dystonia with
Parkinson disease, juvenile
Parkinson disease, treatment of
Parkinsonism syndrome
peptides, brain
periodic paralysis
periodic paralysis, thyrotoxic
PRKN gene
procyclidine
progressive neurologic disorder
progressive supranuclear palsy
review article
rigidity
running
serotonin
sinemet
spina bifida
spinal muscular atrophy
spinocerebellar ataxia
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subarachnoid hemorrhage
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tetrabenazine
toe walking
Tolosa Hunt syndrome
tonic foot response
torticollis
treatment of neurologic disorder
tremor
tremor, postural
trinucleotide repeats
varicella zoster virus
varicella zoster virus, encephalitis
wheelchair
writers cramp
Showing articles 200 to 250 of 1514 << Previous Next >>

A Meta-Regression of the Long-Term Effects of Deep Brain Stimulation on Balance and Gait in PD
Neurol 75:1292-1299, St. George,R.J.,et al, 2010

What Predicts Mortality in Parkinson Disease? A Prospective Population-Based Long-Term Study
Neurol 75:1270-1276, Forsaa,E.B.,et al, 2010

Traumatic Brain Injury - Football, Warfare, and Long-Term Effects
NEJM 363:1293-1296, DeKosky,S.T.,et al, 2010

Dysexecutive Syndrome: Diagnostic Criteria and Validation Study
Ann Neurol 68:855-864, Godefroy,O.,et al, 2010

Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Arch Neurol 67:58-63, Rabinak,C. &Nirenberg,M., 2010

Practice Parameter: Treatment of Nonmotor Symptoms of Parkinson Disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 74:924-931, Zesiewicz,T.A.,et al, 2010

(-Synuclein Accumulation in Skin Nerve Fibers Revealed by Skin Biopsy in Pure Autonomic Failure
Neurol 74:608-610,536, Shishido,T.,et al, 2010

A Multidisciplinary Study of Patients with Early-Onset PD with and Without Parkin Mutations
Neurol 72:110-116,106, Lohmann,E.,et al, 2009

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients with Advanced Parkinson Disease: A Randomized Controlled Trial
JAMA 301:63-73,104, Weaver,F.M.,et al, 2009

Othello Syndrome in Parkinson Disease Patients Without Dementia
The Neurologist 15:34-36, Cannas,A.,et al, 2009

Overweight After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Long Term Follow-Up
JNNP 80:484-488, Bannier,S.,et al, 2009

High-Resolution Diffusion Tensor Imaging in the Substantia Nigra of De Novo Parkinson Disease
Neurol 72:1378-1384,1374, Vaillancourt,D.E.,et al, 2009

Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol 66:563-570, Parkinson Sutdy Group CALM Cohort Investigators, 2009

Parkinsonism in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Neurol 73:401-403, Tisch,S. &Brew,B., 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

A 75-Year-Old Woman with Progressive Right-Hand Tremor and Inability to Use Her Right Side
Neurol 73:1399-1405, Kertesz,A.,et al, 2009

Family History of Melanoma and Parkinson Disease Risk
Neurol 73:1286-1291, Gao,X.,et al, 2009

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009

Road Safety in Drivers With Parkinson Disease
Neurol 73:2112-2119, Uc,E.,et al, 2009

Imaging-Pathologic Correlation in Corticobasal Degeneration
AJNR 30:1884-1892, Tokumaru,A.,et al, 2009

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Levodopa for the Treatment of Parkinsons Disease
NEJM 359:2468-2476, LeWitt,P.A., 2008

Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008

Fourteen-Year Final Report of the Randomized PDRG-UK Trial Comparing Three Treatments in PD
Neurol 71:474-480.470, Katzenschlager,R.,et al., 2008

Second Consensus Statement on the Diagnosis of Multiple System Atrophy
Neurol 71:670-676, Gilman,S.,et al., 2008

Attempted and Completed Suicides After Subthalamic Nucleus Stimulation for Parkinsons Disease
JNNP 79:952-954, Soulas,T.,et al., 2008

Rhinorrhea and Olfaction in Parkinson Disease
Neurol 70:487-489, Friedman, J.H.,et al, 2008

Fragile X-Associated Tremor/Ataxia Syndrome: An Aging Face of the Fragile X Gene
Arch Neurol 65:19-25, Amiri,K.,et al, 2008

Increased Risk of Parkinsonism in Women Who Underwent Oophorectomy Before Menopause
Neurol 70:200-209, Rocca,W.A.,et al, 2008

Functional Imaging of the Cerebral Olfactory System in Patients with Parkinsons Disease
JNNP 79:19-24, Westermann,B.,et al, 2008

a-Synuclein Gene Duplication Is Present in Sporadic Parkinson Disease
Neurol 70:43-49,7, Ahn,T.-B.,et al, 2008

A 23-Year-Old Man With Seizures and Visual Deficit
Neurol 70:73-78, Boustany,R.-M.,et al, 2008

Statin Use and the Risk of Parkinson Disease
Neurol 70:1418-1422, Wahner,A.D.,et al, 2008

Use of Antihypertensives and the Risk of Parkinson Disease
Neurol 70:1438-1444, Becker,C.,et al, 2008

Functional Imaging in Parkinson Disease
Neurol 70:1478-1488, Nandhagopal,R.,et al, 2008

Dementia and Survival in Parkinson Disease: A 12-Year Population Study
Neurol 70:1017-1022, Buter,T.C.,et al, 2008

Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008

Association of Olfactory Dysfunction With Risk for Future Parkinsons Disease
Ann Neurol 63:167-173,132, Ross,G.W.,et al, 2008

Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008

Invited Article: Nervous System Pathology in Sporadic Parkinson Disease
Neurol 70:1916-1925, Braak,H. & Del Tredici,K., 2008

Reversible Parkinsonism and Ataxia Associated With High-Dose Octreotide
Neurol 70:2345-2346, Espay,A.J., 2008

Serum Uric Acid and Clinical Progression in Parkinson Disease: Potential Biomarker for Nigrostriatal Failure
Arch Neurol 65:698-699, Schiess,M. &Oh,I., 2008

Bilateral Basal Ganglia Lesions in Patients with End-Stage Diabetic Nephropathy
Nephrology 13:68-72, Li, J.,et al, 2008

The Syndrome of Bilateral Basal Ganglia Lesions in Diabetic Uremic Patients Presenting with a Relapsing and Remitting Course: A Case Report
Acta Neurol Taiwan 16:226-230, Sheu, Y.,et al, 2007

Acute Reversible Hemi-Parkinsonism for a Diabetic Uremic Patient: Findings from MRI, MRS, FDG-PET, 99m Tc-TRODAT-1 SPECT, and TMS Studies
Ann Nucl Med Sci 20:51-57, Cheng, S.,et al, 2007

Ropinirole 24-Hour Prolonged Release: Randomized, Controlled Study in Advanced Parkinson Disease
Neurol 68:1108-1115, Pahwa,R.,et al, 2007

Improvement of Gait by Chronic, High Doses of Methylphenidate in Patients with Advanced Parkinsons Disease
JNNP 78:470-475, Devos,D.,et al, 2007

Pathological Gambling after Bilateral Subthalamic Nucleus Stimulation in Parkinson Disease
JNNP 78:517-519, Smeding,H.M.M.,et al, 2007



Showing articles 200 to 250 of 1514 << Previous Next >>